-
1
-
-
0033769924
-
What are the important allergens in grass pollen that are linked to human allergic disease?
-
Suphioglu, C. 2000. What are the important allergens in grass pollen that are linked to human allergic disease? Clin. Exp. Allergy 30: 1335-1341.
-
(2000)
Clin. Exp. Allergy
, vol.30
, pp. 1335-1341
-
-
Suphioglu, C.1
-
2
-
-
84886285872
-
Multiple grass mixes as opposed to single grasses for allergen immunotherapy in allergic rhinitis
-
Gangl, K., V. Niederberger, and R. Valenta. 2013. Multiple grass mixes as opposed to single grasses for allergen immunotherapy in allergic rhinitis. Clin. Exp. Allergy 43: 1202-1216.
-
(2013)
Clin. Exp. Allergy
, vol.43
, pp. 1202-1216
-
-
Gangl, K.1
Niederberger, V.2
Valenta, R.3
-
3
-
-
0023726312
-
Epidemiology of emergency room asthma in northern California: Association with IgE antibody to ryegrass pollen
-
Pollart, S. M., M. J. Reid, J. A. Fling, M. D. Chapman, and T. A. Platts-Mills. 1988. Epidemiology of emergency room asthma in northern California: association with IgE antibody to ryegrass pollen. J. Allergy Clin. Immunol. 82: 224-230.
-
(1988)
J. Allergy Clin. Immunol.
, vol.82
, pp. 224-230
-
-
Pollart, S.M.1
Reid, M.J.2
Fling, J.A.3
Chapman, M.D.4
Platts-Mills, T.A.5
-
4
-
-
84937023045
-
Exacerbation of atopic dermatitis on grass pollen exposure in an environmental challenge chamber
-
Werfel, T., A. Heratizadeh, M. Niebuhr, A. Kapp, L. M. Roesner, A. Karch, V. J. Erpenbeck, C. Losche, T. Jung, N. Krug, et al. 2015. Exacerbation of atopic dermatitis on grass pollen exposure in an environmental challenge chamber. J. Allergy Clin. Immunol. 136: 96-103.e9.
-
(2015)
J. Allergy Clin. Immunol.
, vol.136
, pp. 96-96e9
-
-
Werfel, T.1
Heratizadeh, A.2
Niebuhr, M.3
Kapp, A.4
Roesner, L.M.5
Karch, A.6
Erpenbeck, V.J.7
Losche, C.8
Jung, T.9
Krug, N.10
-
5
-
-
70349211808
-
GA2LEN skin test study II: Clinical relevance of inhalant allergen sensitizations in Europe
-
Burbach, G. J., L. M. Heinzerling, G. Edenharter, C. Bachert, C. Bindslev-Jensen, S. Bonini, J. Bousquet, L. Bousquet-Rouanet, P. J. Bousquet, M. Bresciani, et al. 2009. GA2LEN skin test study II: clinical relevance of inhalant allergen sensitizations in Europe. Allergy 64: 1507-1515.
-
(2009)
Allergy
, vol.64
, pp. 1507-1515
-
-
Burbach, G.J.1
Heinzerling, L.M.2
Edenharter, G.3
Bachert, C.4
Bindslev-Jensen, C.5
Bonini, S.6
Bousquet, J.7
Bousquet-Rouanet, L.8
Bousquet, P.J.9
Bresciani, M.10
-
6
-
-
0013855374
-
Isoallergens from rye grass pollen
-
Johnson, P., and D. G. Marsh. 1965. Isoallergens from rye grass pollen. Nature 206: 935-937.
-
(1965)
Nature
, vol.206
, pp. 935-937
-
-
Johnson, P.1
Marsh, D.G.2
-
7
-
-
40749148537
-
Different allergenic activity of grass pollen allergens revealed by skin testing
-
Westritschnig, K., F. Horak, I. Swoboda, N. Balic, S. Spitzauer,M. Kundi, H. Fiebig, R. Suck, O. Cromwell, and R. Valenta. 2008. Different allergenic activity of grass pollen allergens revealed by skin testing. Eur. J. Clin. Invest. 38: 260-267.
-
(2008)
Eur. J. Clin. Invest.
, vol.38
, pp. 260-267
-
-
Westritschnig, K.1
Horak, F.2
Swoboda, I.3
Balic, N.4
Spitzauer, S.5
Kundi, M.6
Fiebig, H.7
Suck, R.8
Cromwell, O.9
Valenta, R.10
-
8
-
-
0029999353
-
Common IgE-epitopes of recombinant Phl p I, the major timothy grass pollen allergen and natural group i grass pollen isoallergens
-
Laffer, S., M. Duchene, I. Reimitzer, M. Susani, C. Mannhalter, D. Kraft, and R. Valenta. 1996. Common IgE-epitopes of recombinant Phl p I, the major timothy grass pollen allergen and natural group I grass pollen isoallergens. Mol. Immunol. 33: 417-426.
-
(1996)
Mol. Immunol.
, vol.33
, pp. 417-426
-
-
Laffer, S.1
Duchene, M.2
Reimitzer, I.3
Susani, M.4
Mannhalter, C.5
Kraft, D.6
Valenta, R.7
-
9
-
-
0029559917
-
T-cell epitopes of Phl p 1, major pollen allergen of timothy grass (Phleum pratense): Evidence for crossreacting and non-crossreacting T-cell epitopes within grass group i allergens
-
Schenk, S., H. Breiteneder, M. Susani, N. Najafian, S. Laffer, M. Duchêne, R. Valenta, G. Fischer, O. Scheiner, D. Kraft, et al. 1995. T-cell epitopes of Phl p 1, major pollen allergen of timothy grass (Phleum pratense): evidence for crossreacting and non-crossreacting T-cell epitopes within grass group I allergens. J. Allergy Clin. Immunol. 96: 986-996.
-
(1995)
J. Allergy Clin. Immunol.
, vol.96
, pp. 986-996
-
-
Schenk, S.1
Breiteneder, H.2
Susani, M.3
Najafian, N.4
Laffer, S.5
Duchêne, M.6
Valenta, R.7
Fischer, G.8
Scheiner, O.9
Kraft, D.10
-
10
-
-
0031924659
-
IgE antibodies to recombinant pollen allergens (Phl p 1, Phl p 2, Phl p 5, and Bet v 2) account for a high percentage of grass pollen-specific IgE
-
Niederberger, V., S. Laffer, R. Fröschl, D. Kraft, H. Rumpold, S. Kapiotis, R. Valenta, and S. Spitzauer. 1998. IgE antibodies to recombinant pollen allergens (Phl p 1, Phl p 2, Phl p 5, and Bet v 2) account for a high percentage of grass pollen-specific IgE. J. Allergy Clin. Immunol. 101: 258-264.
-
(1998)
J. Allergy Clin. Immunol.
, vol.101
, pp. 258-264
-
-
Niederberger, V.1
Laffer, S.2
Fröschl, R.3
Kraft, D.4
Rumpold, H.5
Kapiotis, S.6
Valenta, R.7
Spitzauer, S.8
-
11
-
-
0036095437
-
Recombinant marker allergens: Diagnostic gatekeepers for the treatment of allergy
-
Kazemi-Shirazi, L., V. Niederberger, B. Linhart, J. Lidholm, D. Kraft, and R. Valenta. 2002. Recombinant marker allergens: diagnostic gatekeepers for the treatment of allergy. Int. Arch. Allergy Immunol. 127: 259-268.
-
(2002)
Int. Arch. Allergy Immunol.
, vol.127
, pp. 259-268
-
-
Kazemi-Shirazi, L.1
Niederberger, V.2
Linhart, B.3
Lidholm, J.4
Kraft, D.5
Valenta, R.6
-
12
-
-
24644509434
-
Allergen-specific immunotherapy with recombinant grass pollen allergens
-
Jutel, M., L. Jaeger, R. Suck, H. Meyer, H. Fiebig, and O. Cromwell. 2005. Allergen-specific immunotherapy with recombinant grass pollen allergens. J. Allergy Clin. Immunol. 116: 608-613.
-
(2005)
J. Allergy Clin. Immunol.
, vol.116
, pp. 608-613
-
-
Jutel, M.1
Jaeger, L.2
Suck, R.3
Meyer, H.4
Fiebig, H.5
Cromwell, O.6
-
13
-
-
84869128517
-
Molecular spreading and predictive value of preclinical IgE response to Phleum pratense in children with hay fever
-
Hatzler, L., V. Panetta, S. Lau, P. Wagner, R. L. Bergmann, S. Illi, K. E. Bergmann, T. Keil, S. Hofmaier, A. Rohrbach, et al. 2012. Molecular spreading and predictive value of preclinical IgE response to Phleum pratense in children with hay fever. J. Allergy Clin. Immunol. 130: 894-901.e5.
-
(2012)
J. Allergy Clin. Immunol.
, vol.130
, pp. 894-894e5
-
-
Hatzler, L.1
Panetta, V.2
Lau, S.3
Wagner, P.4
Bergmann, R.L.5
Illi, S.6
Bergmann, K.E.7
Keil, T.8
Hofmaier, S.9
Rohrbach, A.10
-
14
-
-
0016441705
-
Maximal rise in IgE antibody following ragweed pollination season
-
Henderson, L. L., J. B. Larson, and G. J. Gleich. 1975. Maximal rise in IgE antibody following ragweed pollination season. J. Allergy Clin. Immunol. 55: 10-15.
-
(1975)
J. Allergy Clin. Immunol.
, vol.55
, pp. 10-15
-
-
Henderson, L.L.1
Larson, J.B.2
Gleich, G.J.3
-
15
-
-
34447132918
-
Specific immunotherapy has long-term preventive effect of seasonal and perennial asthma: 10-year follow-up on the PAT study
-
Jacobsen, L., B. Niggemann, S. Dreborg, H. A. Ferdousi, S. Halken, A. Høst, A. Koivikko, L. A. Norberg, E. Valovirta, U. Wahn, and C. Möller, The PAT Investigator Group). 2007. Specific immunotherapy has long-term preventive effect of seasonal and perennial asthma: 10-year follow-up on the PAT study. Allergy 62: 943-948.
-
(2007)
Allergy
, vol.62
, pp. 943-948
-
-
Jacobsen, L.1
Niggemann, B.2
Dreborg, S.3
Ferdousi, H.A.4
Halken, S.5
Høst, A.6
Koivikko, A.7
Norberg, L.A.8
Valovirta, E.9
Wahn, U.10
Möller, C.11
-
16
-
-
0033549827
-
Long-term clinical efficacy of grass-pollen immunotherapy
-
Durham, S. R., S. M. Walker, E. M. Varga, M. R. Jacobson, F. O'Brien, W. Noble, S. J. Till, Q. A. Hamid, and K. T. Nouri-Aria. 1999. Long-term clinical efficacy of grass-pollen immunotherapy. N. Engl. J. Med. 341: 468-475.
-
(1999)
N. Engl. J. Med.
, vol.341
, pp. 468-475
-
-
Durham, S.R.1
Walker, S.M.2
Varga, E.M.3
Jacobson, M.R.4
O'Brien, F.5
Noble, W.6
Till, S.J.7
Hamid, Q.A.8
Nouri-Aria, K.T.9
-
17
-
-
0043264799
-
Allergen-specific immunotherapy with a monophosphoryl lipid Aadjuvanted vaccine: Reduced seasonally boosted immunoglobulin e production and inhibition of basophil histamine release by therapy-induced blocking antibodies
-
Mothes, N., M. Heinzkill, K. J. Drachenberg, W. R. Sperr, M. T. Krauth, Y. Majlesi, H. Semper, P. Valent, V. Niederberger, D. Kraft, and R. Valenta. 2003. Allergen-specific immunotherapy with a monophosphoryl lipid Aadjuvanted vaccine: reduced seasonally boosted immunoglobulin E production and inhibition of basophil histamine release by therapy-induced blocking antibodies. Clin. Exp. Allergy 33: 1198-1208.
-
(2003)
Clin. Exp. Allergy
, vol.33
, pp. 1198-1208
-
-
Mothes, N.1
Heinzkill, M.2
Drachenberg, K.J.3
Sperr, W.R.4
Krauth, M.T.5
Majlesi, Y.6
Semper, H.7
Valent, P.8
Niederberger, V.9
Kraft, D.10
Valenta, R.11
-
18
-
-
5144222703
-
Vaccination with genetically engineered allergens prevents progression of allergic disease
-
Niederberger, V., F. Horak, S. Vrtala, S. Spitzauer, M. T. Krauth, P. Valent, J. Reisinger, M. Pelzmann, B. Hayek, M. Kronqvist, et al. 2004. Vaccination with genetically engineered allergens prevents progression of allergic disease. Proc. Natl. Acad. Sci. USA 101(Suppl. 2): 14677-14682.
-
(2004)
Proc. Natl. Acad. Sci. USA
, vol.101
, pp. 14677-14682
-
-
Niederberger, V.1
Horak, F.2
Vrtala, S.3
Spitzauer, S.4
Krauth, M.T.5
Valent, P.6
Reisinger, J.7
Pelzmann, M.8
Hayek, B.9
Kronqvist, M.10
-
19
-
-
33749436870
-
Immunotherapy with a ragweed-Toll-like receptor 9 agonist vaccine for allergic rhinitis
-
Creticos, P. S., J. T. Schroeder, R. G. Hamilton, S. L. Balcer-Whaley, A. P. Khattignavong, R. Lindblad, H. Li, R. Coffman, V. Seyfert, J. J. Eiden, and D. Broide, Immune Tolerance Network Group. 2006. Immunotherapy with a ragweed-Toll-like receptor 9 agonist vaccine for allergic rhinitis. N. Engl. J. Med. 355: 1445-1455.
-
(2006)
N. Engl. J. Med.
, vol.355
, pp. 1445-1455
-
-
Creticos, P.S.1
Schroeder, J.T.2
Hamilton, R.G.3
Balcer-Whaley, S.L.4
Khattignavong, A.P.5
Lindblad, R.6
Li, H.7
Coffman, R.8
Seyfert, V.9
Eiden, J.J.10
Broide, D.11
Tolerance Network Group, I.12
-
20
-
-
84956662881
-
IgE responses to exogenous and endogenous allergens in atopic dermatitis patients under long-term systemic cyclosporine A treatment
-
Lucae, S., P. Schmid-Grendelmeier, B. Wuthrich, D. Kraft, R. Valenta, and B. Linhart. 2016. IgE responses to exogenous and endogenous allergens in atopic dermatitis patients under long-term systemic cyclosporine A treatment. Allergy 71: 115-118.
-
(2016)
Allergy
, vol.71
, pp. 115-118
-
-
Lucae, S.1
Schmid-Grendelmeier, P.2
Wuthrich, B.3
Kraft, D.4
Valenta, R.5
Linhart, B.6
-
21
-
-
84902437071
-
Persistence of IgE-associated allergy and allergen-specific IgE despite CD4+ T cell loss in AIDS
-
Marth, K., E. Wollmann, D. Gallerano, P. Ndlovu, I. Makupe, R. Valenta, and E. Sibanda. 2014. Persistence of IgE-associated allergy and allergen-specific IgE despite CD4+ T cell loss in AIDS. PLoS One 9: e97893.
-
(2014)
PLoS One
, vol.9
, pp. e97893
-
-
Marth, K.1
Wollmann, E.2
Gallerano, D.3
Ndlovu, P.4
Makupe, I.5
Valenta, R.6
Sibanda, E.7
-
22
-
-
33947263596
-
Costimulation blockade inhibits allergic sensitization but does not affect established allergy in a murine model of grass pollen allergy
-
Linhart, B., S. Bigenzahn, A. Hartl, C. Lupinek, J. Thalhamer, R. Valenta, and T. Wekerle. 2007. Costimulation blockade inhibits allergic sensitization but does not affect established allergy in a murine model of grass pollen allergy. J. Immunol. 178: 3924-3931.
-
(2007)
J. Immunol.
, vol.178
, pp. 3924-3931
-
-
Linhart, B.1
Bigenzahn, S.2
Hartl, A.3
Lupinek, C.4
Thalhamer, J.5
Valenta, R.6
Wekerle, T.7
-
23
-
-
84890816552
-
OX40L blockade and allergen-induced airway responses in subjects with mild asthma
-
Gauvreau, G. M., L. P. Boulet, D. W. Cockcroft, J. M. FitzGerald, I. Mayers, C. Carlsten, M. Laviolette, K. J. Killian, B. E. Davis, M. Larché, et al. 2014. OX40L blockade and allergen-induced airway responses in subjects with mild asthma. Clin. Exp. Allergy 44: 29-37.
-
(2014)
Clin. Exp. Allergy
, vol.44
, pp. 29-37
-
-
Gauvreau, G.M.1
Boulet, L.P.2
Cockcroft, D.W.3
FitzGerald, J.M.4
Mayers, I.5
Carlsten, C.6
Laviolette, M.7
Killian, K.J.8
Davis, B.E.9
Larché, M.10
-
24
-
-
84943452181
-
Development and characterization of a recombinant, hypoallergenic, peptide-based vaccine for grass pollen allergy
-
Focke-Tejkl, M., M.Weber, K. Niespodziana, A. Neubauer, H. Huber, R. Henning, G. Stegfellner, B. Maderegger, M. Hauer, F. Stolz, et al. 2015. Development and characterization of a recombinant, hypoallergenic, peptide-based vaccine for grass pollen allergy. J. Allergy Clin. Immunol. 135: 1207.e1-1207.e11.
-
(2015)
J. Allergy Clin. Immunol.
, vol.135
, pp. 1207e1-1207e11
-
-
Focke-Tejkl, M.1
Weber, M.2
Niespodziana, K.3
Neubauer, A.4
Huber, H.5
Henning, R.6
Stegfellner, G.7
Maderegger, B.8
Hauer, M.9
Stolz, F.10
-
25
-
-
0035464780
-
Nonanaphylactic synthetic peptides derived from B cell epitopes of the major grass pollen allergen, Phl p 1, for allergy vaccination
-
Focke, M., V. Mahler, T. Ball, W. R. Sperr, Y. Majlesi, P. Valent, D. Kraft, and R. Valenta. 2001. Nonanaphylactic synthetic peptides derived from B cell epitopes of the major grass pollen allergen, Phl p 1, for allergy vaccination. FASEB J. 15: 2042-2044.
-
(2001)
FASEB J.
, vol.15
, pp. 2042-2044
-
-
Focke, M.1
Mahler, V.2
Ball, T.3
Sperr, W.R.4
Majlesi, Y.5
Valent, P.6
Kraft, D.7
Valenta, R.8
-
26
-
-
0014949207
-
Cleavage of structural proteins during the assembly of the head of bacteriophage T4
-
Laemmli, U. K. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227: 680-685.
-
(1970)
Nature
, vol.227
, pp. 680-685
-
-
Laemmli, U.K.1
-
27
-
-
23244456566
-
Intranasal tolerance induction with polypeptides derived from 3 noncross-reactive major aeroallergens prevents allergic polysensitization in mice
-
Hufnagl, K., B. Winkler, M. Focke, R. Valenta, O. Scheiner, H. Renz, and U. Wiedermann. 2005. Intranasal tolerance induction with polypeptides derived from 3 noncross-reactive major aeroallergens prevents allergic polysensitization in mice. J. Allergy Clin. Immunol. 116: 370-376.
-
(2005)
J. Allergy Clin. Immunol.
, vol.116
, pp. 370-376
-
-
Hufnagl, K.1
Winkler, B.2
Focke, M.3
Valenta, R.4
Scheiner, O.5
Renz, H.6
Wiedermann, U.7
-
28
-
-
33846837501
-
Molecular determinants of allergen-induced effector cell degranulation
-
Gieras, A., M. Focke-Tejkl, T. Ball, P. Verdino, A. Hartl, J. Thalhamer, and R. Valenta. 2007. Molecular determinants of allergen-induced effector cell degranulation. J. Allergy Clin. Immunol. 119: 384-390.
-
(2007)
J. Allergy Clin. Immunol.
, vol.119
, pp. 384-390
-
-
Gieras, A.1
Focke-Tejkl, M.2
Ball, T.3
Verdino, P.4
Hartl, A.5
Thalhamer, J.6
Valenta, R.7
-
29
-
-
1042275745
-
Circular dichroism analysis of allergens
-
Verdino, P., and W. Keller. 2004. Circular dichroism analysis of allergens. Methods 32: 241-248.
-
(2004)
Methods
, vol.32
, pp. 241-248
-
-
Verdino, P.1
Keller, W.2
-
30
-
-
84892707552
-
Prophylactic and therapeutic vaccination with carrier-bound Bet v 1 peptides lacking allergen-specific T cell epitopes reduces Bet v 1-specific T cell responses via blocking antibodies in a murine model for birch pollen allergy
-
Linhart, B., M. Narayanan, M. Focke-Tejkl, F. Wrba, S. Vrtala, and R. Valenta. 2014. Prophylactic and therapeutic vaccination with carrier-bound Bet v 1 peptides lacking allergen-specific T cell epitopes reduces Bet v 1-specific T cell responses via blocking antibodies in a murine model for birch pollen allergy. Clin. Exp. Allergy 44: 278-287.
-
(2014)
Clin. Exp. Allergy
, vol.44
, pp. 278-287
-
-
Linhart, B.1
Narayanan, M.2
Focke-Tejkl, M.3
Wrba, F.4
Vrtala, S.5
Valenta, R.6
-
31
-
-
79955549894
-
Mapping of conformational IgE epitopes with peptide-specific monoclonal antibodies reveals simultaneous binding of different IgE antibodies to a surface patch on the major birch pollen allergen, Bet v 1
-
Gieras, A., P. Cejka, K. Blatt, M. Focke-Tejkl, B. Linhart, S. Flicker, A. Stoecklinger, K. Marth, A. Drescher, J. Thalhamer, et al. 2011. Mapping of conformational IgE epitopes with peptide-specific monoclonal antibodies reveals simultaneous binding of different IgE antibodies to a surface patch on the major birch pollen allergen, Bet v 1. J. Immunol. 186: 5333-5344.
-
(2011)
J. Immunol.
, vol.186
, pp. 5333-5344
-
-
Gieras, A.1
Cejka, P.2
Blatt, K.3
Focke-Tejkl, M.4
Linhart, B.5
Flicker, S.6
Stoecklinger, A.7
Marth, K.8
Drescher, A.9
Thalhamer, J.10
-
32
-
-
15444353066
-
Immunization with purified natural and recombinant allergens induces mouse IgG1 antibodies that recognize similar epitopes as human IgE and inhibit the human IgE-allergen interaction and allergen-induced basophil degranulation
-
Vrtala, S., T. Ball, S. Spitzauer, B. Pandjaitan, C. Suphioglu, B. Knox,W. R. Sperr, P. Valent, D. Kraft, and R. Valenta. 1998. Immunization with purified natural and recombinant allergens induces mouse IgG1 antibodies that recognize similar epitopes as human IgE and inhibit the human IgE-allergen interaction and allergen-induced basophil degranulation. J. Immunol. 160: 6137-6144.
-
(1998)
J. Immunol.
, vol.160
, pp. 6137-6144
-
-
Vrtala, S.1
Ball, T.2
Spitzauer, S.3
Pandjaitan, B.4
Suphioglu, C.5
Knox, B.6
Sperr, W.R.7
Valent, P.8
Kraft, D.9
Valenta, R.10
-
33
-
-
0034995872
-
Efficacy of soluble IL-4 receptor for the treatment of adults with asthma
-
Borish, L. C., H. S. Nelson, J. Corren, G. Bensch,W.W. Busse, J. B.Whitmore, and J. M. Agosti, IL-4R Asthma Study Group. 2001. Efficacy of soluble IL-4 receptor for the treatment of adults with asthma. J. Allergy Clin. Immunol. 107: 963-970.
-
(2001)
J. Allergy Clin. Immunol.
, vol.107
, pp. 963-970
-
-
Borish, L.C.1
Nelson, H.S.2
Corren, J.3
Bensch, G.4
Busse, W.W.5
Whitmore, J.B.6
Agosti, J.M.7
Asthma Study Group, I.8
-
34
-
-
84904490534
-
Targeting membrane-expressed IgE B cell receptor with an antibody to the M1 prime epitope reduces IgE production
-
Gauvreau, G. M., J. M. Harris, L. P. Boulet, H. Scheerens, J. M. Fitzgerald, W. S. Putnam, D. W. Cockcroft, B. E. Davis, R. Leigh, Y. Zheng, et al. 2014. Targeting membrane-expressed IgE B cell receptor with an antibody to the M1 prime epitope reduces IgE production. Sci. Transl. Med. 6: 243ra85.
-
(2014)
Sci. Transl. Med.
, vol.6
, pp. 243ra85
-
-
Gauvreau, G.M.1
Harris, J.M.2
Boulet, L.P.3
Scheerens, H.4
Fitzgerald, J.M.5
Putnam, W.S.6
Cockcroft, D.W.7
Davis, B.E.8
Leigh, R.9
Zheng, Y.10
-
35
-
-
33749016485
-
Immunological mechanisms of allergen-specific immunotherapy
-
Larché, M., C. A. Akdis, and R. Valenta. 2006. Immunological mechanisms of allergen-specific immunotherapy. Nat. Rev. Immunol. 6: 761-771.
-
(2006)
Nat. Rev. Immunol.
, vol.6
, pp. 761-771
-
-
Larché, M.1
Akdis, C.A.2
Valenta, R.3
-
36
-
-
0036182689
-
Evolution of IgM, IgE and IgG1-4 antibody responses in early childhood monitored with recombinant allergen components: Implications for class switch mechanisms
-
Niederberger, V., B. Niggemann, D. Kraft, S. Spitzauer, and R. Valenta. 2002. Evolution of IgM, IgE and IgG1-4 antibody responses in early childhood monitored with recombinant allergen components: implications for class switch mechanisms. Eur. J. Immunol. 32: 576-584.
-
(2002)
Eur. J. Immunol.
, vol.32
, pp. 576-584
-
-
Niederberger, V.1
Niggemann, B.2
Kraft, D.3
Spitzauer, S.4
Valenta, R.5
-
37
-
-
84897115704
-
The production and regulation of IgE by the immune system
-
Wu, L. C., and A. A. Zarrin. 2014. The production and regulation of IgE by the immune system. Nat. Rev. Immunol. 14: 247-259.
-
(2014)
Nat. Rev. Immunol.
, vol.14
, pp. 247-259
-
-
Wu, L.C.1
Zarrin, A.A.2
-
38
-
-
84862777318
-
IgE+ memory B cells and plasma cells generated through a germinal-center pathway
-
Talay, O., D. Yan, H. D. Brightbill, E. E. Straney, M. Zhou, E. Ladi, W. P. Lee, J. G. Egen, C. D. Austin, M. Xu, and L. C. Wu. 2012. IgE+ memory B cells and plasma cells generated through a germinal-center pathway. Nat. Immunol. 13: 396-404.
-
(2012)
Nat. Immunol.
, vol.13
, pp. 396-404
-
-
Talay, O.1
Yan, D.2
Brightbill, H.D.3
Straney, E.E.4
Zhou, M.5
Ladi, E.6
Lee, W.P.7
Egen, J.G.8
Austin, C.D.9
Xu, M.10
Wu, L.C.11
-
39
-
-
84862777789
-
Fluorescent in vivo detection reveals that IgE+ B cells are restrained by an intrinsic cell fate predisposition
-
Yang, Z., B. M. Sullivan, and C. D. Allen. 2012. Fluorescent in vivo detection reveals that IgE+ B cells are restrained by an intrinsic cell fate predisposition. Immunity 36: 857-872.
-
(2012)
Immunity
, vol.36
, pp. 857-872
-
-
Yang, Z.1
Sullivan, B.M.2
Allen, C.D.3
-
40
-
-
0032033127
-
Humoral immunity due to long-lived plasma cells
-
Slifka, M. K., R. Antia, J. K. Whitmire, and R. Ahmed. 1998. Humoral immunity due to long-lived plasma cells. Immunity 8: 363-372.
-
(1998)
Immunity
, vol.8
, pp. 363-372
-
-
Slifka, M.K.1
Antia, R.2
Whitmire, J.K.3
Ahmed, R.4
-
41
-
-
84888120685
-
The distinctive germinal center phase of IgE+ B lymphocytes limits their contribution to the classical memory response
-
He, J. S., M. Meyer-Hermann, D. Xiangying, L. Y. Zuan, L. A. Jones, L. Ramakrishna, V. C. de Vries, J. Dolpady, H. Aina, S. Joseph, et al. 2013. The distinctive germinal center phase of IgE+ B lymphocytes limits their contribution to the classical memory response. J. Exp. Med. 210: 2755-2771.
-
(2013)
J. Exp. Med.
, vol.210
, pp. 2755-2771
-
-
He, J.S.1
Meyer-Hermann, M.2
Xiangying, D.3
Zuan, L.Y.4
Jones, L.A.5
Ramakrishna, L.6
De Vries, V.C.7
Dolpady, J.8
Aina, H.9
Joseph, S.10
-
42
-
-
78649828969
-
Nasal application of rBet v 1 or non-IgE-reactive T-cell epitope-containing rBet v 1 fragments has different effects on systemic allergen-specific antibody responses
-
Egger, C., F. Horak, S. Vrtala, R. Valenta, and V. Niederberger. 2010. Nasal application of rBet v 1 or non-IgE-reactive T-cell epitope-containing rBet v 1 fragments has different effects on systemic allergen-specific antibody responses. J. Allergy Clin. Immunol. 126: 1312-1315.e4.
-
(2010)
J. Allergy Clin. Immunol.
, vol.126
, pp. 1312-1312e4
-
-
Egger, C.1
Horak, F.2
Vrtala, S.3
Valenta, R.4
Niederberger, V.5
-
43
-
-
84907952527
-
The high molecular weight glutenin subunit Bx7 allergen from wheat contains repetitive IgE epitopes
-
Baar, A., S. Pahr, C. Constantin, S. Giavi, N. G. Papadopoulos, A. S. Pelkonen, M. J. Mäkelä, S. Scheiblhofer, J. Thalhamer, M. Weber, et al. 2014. The high molecular weight glutenin subunit Bx7 allergen from wheat contains repetitive IgE epitopes. Allergy 69: 1316-1323.
-
(2014)
Allergy
, vol.69
, pp. 1316-1323
-
-
Baar, A.1
Pahr, S.2
Constantin, C.3
Giavi, S.4
Papadopoulos, N.G.5
Pelkonen, A.S.6
Mäkelä, M.J.7
Scheiblhofer, S.8
Thalhamer, J.9
Weber, M.10
-
44
-
-
77949361437
-
Transient dimers of allergens
-
Rouvinen, J., J. Jänis, M. L. Laukkanen, S. Jylhä, M. Niemi, T. Päivinen, S. Mäkinen-Kiljunen, T. Haahtela, H. Söderlund, and K. Takkinen. 2010. Transient dimers of allergens. PLoS One 5: e9037.
-
(2010)
PLoS One
, vol.5
, pp. e9037
-
-
Rouvinen, J.1
Jänis, J.2
Laukkanen, M.L.3
Jylhä, S.4
Niemi, M.5
Päivinen, T.6
Mäkinen-Kiljunen, S.7
Haahtela, T.8
Söderlund, H.9
Takkinen, K.10
-
45
-
-
27744514242
-
Dimerization of the major birch pollen allergen Bet v 1 is important for its in vivo IgE-cross-linking potential in mice
-
Schöll, I., N. Kalkura, Y. Shedziankova, A. Bergmann, P. Verdino, R. Knittelfelder, T. Kopp, B. Hantusch, C. Betzel, K. Dierks, et al. 2005. Dimerization of the major birch pollen allergen Bet v 1 is important for its in vivo IgE-cross-linking potential in mice. J. Immunol. 175: 6645-6650.
-
(2005)
J. Immunol.
, vol.175
, pp. 6645-6650
-
-
Schöll, I.1
Kalkura, N.2
Shedziankova, Y.3
Bergmann, A.4
Verdino, P.5
Knittelfelder, R.6
Kopp, T.7
Hantusch, B.8
Betzel, C.9
Dierks, K.10
-
46
-
-
21844457947
-
Development of an in vitro system for the study of allergens and allergen-specific immunoglobulin e and immunoglobulin G: Fc? Receptor i supercross-linking is a possible new mechanism of immunoglobulin G-dependent enhancement of type i allergic reactions
-
Sellge, G., S. Laffer, C. Mierke, S. Vrtala, M. W. Hoffmann, J. Klempnauer, M. P. Manns, R. Valenta, and S. C. Bischoff. 2005. Development of an in vitro system for the study of allergens and allergen-specific immunoglobulin E and immunoglobulin G: Fc? receptor I supercross-linking is a possible new mechanism of immunoglobulin G-dependent enhancement of type I allergic reactions. Clin. Exp. Allergy 35: 774-781.
-
(2005)
Clin. Exp. Allergy
, vol.35
, pp. 774-781
-
-
Sellge, G.1
Laffer, S.2
Mierke, C.3
Vrtala, S.4
Hoffmann, M.W.5
Klempnauer, J.6
Manns, M.P.7
Valenta, R.8
Bischoff, S.C.9
-
47
-
-
76349094087
-
Developments in allergen-specific immunotherapy: From allergen extracts to allergy vaccines bypassing allergen-specific immunoglobulin e and T cell reactivity
-
Focke, M., I. Swoboda, K. Marth, and R. Valenta. 2010. Developments in allergen-specific immunotherapy: from allergen extracts to allergy vaccines bypassing allergen-specific immunoglobulin E and T cell reactivity. Clin. Exp. Allergy 40: 385-397.
-
(2010)
Clin. Exp. Allergy
, vol.40
, pp. 385-397
-
-
Focke, M.1
Swoboda, I.2
Marth, K.3
Valenta, R.4
-
48
-
-
84994807376
-
Mechanisms, safety and efficacy of a B cell epitope-based vaccine for immunotherapy of grass pollen allergy
-
Zieglmayer, P., M. Focke-Tejkl, R. Schmutz, P. Lemell, R. Zieglmayer, M. Weber, R. Kiss, K. Blatt, P. Valent, F. Stolz, et al. 2016. Mechanisms, safety and efficacy of a B cell epitope-based vaccine for immunotherapy of grass pollen allergy. EBioMedicine 11: 43-57.
-
(2016)
EBioMedicine
, vol.11
, pp. 43-57
-
-
Zieglmayer, P.1
Focke-Tejkl, M.2
Schmutz, R.3
Lemell, P.4
Zieglmayer, R.5
Weber, M.6
Kiss, R.7
Blatt, K.8
Valent, P.9
Stolz, F.10
-
49
-
-
84994853780
-
Immunotherapy with the preS-based grass pollen allergy vaccine BM32 induces antibody responses protecting against hepatitis B infection
-
Cornelius, C., K. Schöneweis, F. Georgi, M. Weber, V. Niederberger, P. Zieglmayer, K. Niespodziana, M. Trauner, H. Hofer, S. Urban, et al. 2016. Immunotherapy With the preS-based grass pollen allergy vaccine BM32 induces antibody responses protecting against hepatitis B infection. EBioMedicine 11: 58-67.
-
(2016)
EBioMedicine
, vol.11
, pp. 58-67
-
-
Cornelius, C.1
Schöneweis, K.2
Georgi, F.3
Weber, M.4
Niederberger, V.5
Zieglmayer, P.6
Niespodziana, K.7
Trauner, M.8
Hofer, H.9
Urban, S.10
-
50
-
-
84994908970
-
Development of an allergy immunotherapy leads to a new type of hepatitis B vaccine
-
Gerlich, W.H., and D. Glebe. 2016. Development of an allergy immunotherapy leads to a new type of hepatitis B vaccine. EBioMedicine 11: 5-6.
-
(2016)
EBioMedicine
, vol.11
, pp. 5-6
-
-
Gerlich, W.H.1
Glebe, D.2
|